The Zhitong Finance App learned that Lyon released a research report saying that the revenue of Colombotai Bio-B (06990.HK) increased 2.9% year on year in the first half of the year, and commercial revenue increased 112.1% year on year due to SAC-TMT indications and channel expansion. Net profit reached 388 million yuan, higher than market expectations. The bank incorporated performance into the new forecast and raised the target price from HK$500.7 to HK$626.4. Maintain the “outperform the market” rating.

The Zhitong Finance App learned that Lyon released a research report saying that the revenue of Colombotai Bio-B (06990.HK) increased 2.9% year on year in the first half of the year, and commercial revenue increased 112.1% year on year due to SAC-TMT indications and channel expansion. Net profit reached 388 million yuan, higher than market expectations. The bank incorporated performance into the new forecast and raised the target price from HK$500.7 to HK$626.4. Maintain the “outperform the market” rating.